1. Home
  2. FUFU vs EOLS Comparison

FUFU vs EOLS Comparison

Compare FUFU & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUFU
  • EOLS
  • Stock Information
  • Founded
  • FUFU 2020
  • EOLS 2012
  • Country
  • FUFU Singapore
  • EOLS United States
  • Employees
  • FUFU N/A
  • EOLS N/A
  • Industry
  • FUFU
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FUFU
  • EOLS Health Care
  • Exchange
  • FUFU NYSE
  • EOLS Nasdaq
  • Market Cap
  • FUFU 626.3M
  • EOLS 589.3M
  • IPO Year
  • FUFU N/A
  • EOLS 2018
  • Fundamental
  • Price
  • FUFU $3.66
  • EOLS $9.17
  • Analyst Decision
  • FUFU Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • FUFU 3
  • EOLS 5
  • Target Price
  • FUFU $6.60
  • EOLS $23.75
  • AVG Volume (30 Days)
  • FUFU 145.6K
  • EOLS 879.0K
  • Earning Date
  • FUFU 08-19-2025
  • EOLS 08-05-2025
  • Dividend Yield
  • FUFU N/A
  • EOLS N/A
  • EPS Growth
  • FUFU N/A
  • EOLS N/A
  • EPS
  • FUFU 0.01
  • EOLS N/A
  • Revenue
  • FUFU $396,963,000.00
  • EOLS $275,463,000.00
  • Revenue This Year
  • FUFU $15.05
  • EOLS $33.42
  • Revenue Next Year
  • FUFU $70.20
  • EOLS $33.18
  • P/E Ratio
  • FUFU $338.47
  • EOLS N/A
  • Revenue Growth
  • FUFU 7.13
  • EOLS 25.38
  • 52 Week Low
  • FUFU $2.91
  • EOLS $8.67
  • 52 Week High
  • FUFU $6.24
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • FUFU 49.06
  • EOLS 41.04
  • Support Level
  • FUFU $3.51
  • EOLS $8.91
  • Resistance Level
  • FUFU $4.56
  • EOLS $10.20
  • Average True Range (ATR)
  • FUFU 0.23
  • EOLS 0.36
  • MACD
  • FUFU -0.04
  • EOLS -0.02
  • Stochastic Oscillator
  • FUFU 15.24
  • EOLS 9.69

About FUFU BITFUFU INC

BitFuFu Inc is a digital asset mining and cloud-mining service provider that fosters a secure, compliant, and transparent blockchain infrastructure. It provides stable and intelligent digital asset mining solutions, including one-stop cloud-mining services and miner hosting services to institutional customers and individual digital assets. The company generates the majority of its revenue from the sale of cloud-mining solutions, followed by Self-mining revenue. Geographically, the company generates revenue from North America, Asia, Europe, and Others.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: